Ephedra Marketing, Availability Debated At Government Reform Hearing
This article was originally published in The Tan Sheet
Executive Summary
FDA's Center for Food Safety & Applied Nutrition has reached a standoff with industry over how best to regulate ephedrine alkaloid-containing dietary supplements, CFSAN Director Joseph Levitt stated during a House Government Reform Committee hearing on supplement regulation March 20.
You may also be interested in...
Ephedrine Alkaloid AERs Nearly Double Over Two Years - AAPCC Data
Adverse event reports related to ephedrine alkaloid dietary supplement use almost doubled between 1997 and 1999, according to poison control center data cited in a Sept. 5 citizen petition to FDA.
Ephedrine Alkaloid AERs Nearly Double Over Two Years - AAPCC Data
Adverse event reports related to ephedrine alkaloid dietary supplement use almost doubled between 1997 and 1999, according to poison control center data cited in a Sept. 5 citizen petition to FDA.
Ephedrine Alkaloid AERs Nearly Double Over Two Years - AAPCC Data
Adverse event reports related to ephedrine alkaloid dietary supplement use almost doubled between 1997 and 1999, according to poison control center data cited in a Sept. 5 citizen petition to FDA.